Geratherm Medical AG
DB:GME
Germany / Healthcare / Healthcare Equipment & Supplies
Exchange Data
Hide this widget
Price
3.22 EUR
Day change
0.00 (0.00%)
52-week range
2.50 - 5.20
08:07 - Delayed Data
Summary of Geratherm Medical AG
Hide this widget
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and M...
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
Loading chart...
Data Explorer
Hide this widget
Data could not be retrieved
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| GME | Peers | Sector | |
|---|---|---|---|
Market Cap | 17.535 M | 1.011 B | 52.716 M |
Price % of 52 Week High | Premium | 66.6% | 57.5% |
Dividend Yield | 3.1% | 2.1% | 0.0% |
Shareholder Yield | Premium | 0.1% | -0.7% |
1 Year Price Total Return | -20.1% | 0.0% | -16.5% |
Beta (5 Year) | 0.42 | 0.80 | 0.64 |
In the News
Hide this widget
No data available
Fair Value
Hide this widget
Average
–
Upside
–
Uncertainty
–
Spread
–
Financial Health
Health Details
Hide this widget
Financial Health for Geratherm Medical is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
12345
Financial Models for Geratherm Medical AG
Model Gallery
Hide this widget
| DDM Stable GrowthView Updated 22 hours ago |
| DuPont ROE AnalysisView Updated 6 days ago |
| Earnings Power ValueView Updated 22 hours ago |
| 10Y Historical FinancialsView Updated 6 days ago |
| 5Y Historical FinancialsView Updated 6 days ago |
| CAPM WACC ModelView Updated 2 hours ago |
| DDM Multi StageView Updated 22 hours ago |
Historical Financials
Full Financials
Hide this widget
| (EUR in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Jun-24 | Jun-23 | Jun-24 |
| Income Statement | |||||
| Revenue | 26 | 22 | 18 | 5.91 | 4.27 |
| Operating Income | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Net Profit | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Diluted EPS | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| EBITDA | 3.74 | 3.94 | 1.61 | 0.96 | (0.21) |
| Balance Sheet | |||||
| Cash & ST Invest. | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Equity | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Debt | 9.29 | 7.23 | 6.57 | 8.15 | 6.57 |
| Cash Flow Statement | |||||
| Cash Flow Operations | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Investing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Financing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Free Cash Flow | 0.64 | 0.71 | (0.70) | 0.59 | (0.12) |
Analyst Notes
April 11, 2025
Hide this widget